Assessing the burden of treatment-emergent adverse events associated with atypical antipsychotic medications
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-244X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Assessing the burden of treatment-emergent adverse events associated with atypical antipsychotic medications ; volume:17 ; number:1 ; day:13 ; month:2 ; year:2017 ; pages:1-11 ; date:12.2017
BMC psychiatry ; 17, Heft 1 (13.2.2017), 1-11, 12.2017
- Schlagwort
-
Biopharmazie
Pharmakodynamik
Pharmakokinetik
- Urheber
-
Llorca, Pierre-Michel
- Beteiligte Personen und Organisationen
-
Lancon, Christophe
Hartry, Ann
Brown, T. Michelle
DiBenedetti, Dana B.
Kamat, Siddhesh A.
François, Clément
SpringerLink (Online service)
- DOI
-
10.1186/s12888-017-1213-6
- URN
-
urn:nbn:de:1111-201703078507
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:58 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Llorca, Pierre-Michel
- Lancon, Christophe
- Hartry, Ann
- Brown, T. Michelle
- DiBenedetti, Dana B.
- Kamat, Siddhesh A.
- François, Clément
- SpringerLink (Online service)
Ähnliche Objekte (12)
Gender differences in the use of atypical antipsychotic medications for ICU delirium
Efficacy and safety of haloperidol versus atypical antipsychotic medications in the treatment of delirium
High circulating MIF levels indicate the association with atypical antipsychotic-induced adverse metabolic effects
Comparative meta-analysis of the neurotransmitter alterations by antipsychotic medications
Predictors of switching antipsychotic medications in the treatment of schizophrenia
Second-generation antipsychotic medications and metabolic disturbance in children and adolescents
Hyperglycemic adverse events following antipsychotic drug administration in spontaneous adverse event reports
Atypical antipsychotic agents; Peas in a pod or chalk and cheese?
Unlocking treatment success: predicting atypical antipsychotic continuation in youth with mania
Effects of antipsychotic and anticholinergic medications on cognition in chronic patients with schizophrenia
2-Bromoterguride–a potential atypical antipsychotic drug without metabolic effects in rats
Gender and race disparities in weight gain among offenders prescribed antidepressant and antipsychotic medications
Gender differences in the use of atypical antipsychotic medications for ICU delirium
Efficacy and safety of haloperidol versus atypical antipsychotic medications in the treatment of delirium
High circulating MIF levels indicate the association with atypical antipsychotic-induced adverse metabolic effects
Comparative meta-analysis of the neurotransmitter alterations by antipsychotic medications
Predictors of switching antipsychotic medications in the treatment of schizophrenia
Second-generation antipsychotic medications and metabolic disturbance in children and adolescents
Hyperglycemic adverse events following antipsychotic drug administration in spontaneous adverse event reports
Atypical antipsychotic agents; Peas in a pod or chalk and cheese?
Unlocking treatment success: predicting atypical antipsychotic continuation in youth with mania
Effects of antipsychotic and anticholinergic medications on cognition in chronic patients with schizophrenia
2-Bromoterguride–a potential atypical antipsychotic drug without metabolic effects in rats
Gender and race disparities in weight gain among offenders prescribed antidepressant and antipsychotic medications
Gender differences in the use of atypical antipsychotic medications for ICU delirium
Efficacy and safety of haloperidol versus atypical antipsychotic medications in the treatment of delirium
High circulating MIF levels indicate the association with atypical antipsychotic-induced adverse metabolic effects
Comparative meta-analysis of the neurotransmitter alterations by antipsychotic medications
Predictors of switching antipsychotic medications in the treatment of schizophrenia
Second-generation antipsychotic medications and metabolic disturbance in children and adolescents
Hyperglycemic adverse events following antipsychotic drug administration in spontaneous adverse event reports
Atypical antipsychotic agents; Peas in a pod or chalk and cheese?
Unlocking treatment success: predicting atypical antipsychotic continuation in youth with mania
Effects of antipsychotic and anticholinergic medications on cognition in chronic patients with schizophrenia
2-Bromoterguride–a potential atypical antipsychotic drug without metabolic effects in rats